Lumos Pharma climbs on $38 mln go-private deal

Lumos Pharma

23/10/2024 16:24

** Shares of drug developer Lumos Pharma  LUMO.O  rise 11.4%
to $4.40 
    ** Co says it will be acquired by investment firm Double
Point Ventures for about $38 mln in a go-private deal
    ** LUMO says purchase price of $4.25/shr represents a
premium of 7.6% to its previous closing share price of $3.95
    ** Says transaction is expected to close before the end of
2024
    ** Including session's move, stock up 39.3% YTD

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))